Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors

BACKGROUND: Urogenital atrophy (UA) is a common treatment-limiting side effect of endocrine therapies. Topical estrogen is effective but systemic absorption may counter aromatase inhibitor efficacy. Numerous complementary approaches are marketed for use in UA without rigorous testing of their estrog...

Descripción completa

Detalles Bibliográficos
Autores principales: Simões, Bruno M., Kohler, Bertram, Clarke, Robert B., Stringer, Jacqui, Novak-Frazer, Lily, Young, Keely, Rautemaa-Richardson, Riina, Zucchini, Giorgia, Armstrong, Anne, Howell, Sacha J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888815/
https://www.ncbi.nlm.nih.gov/pubmed/29636827
http://dx.doi.org/10.1177/1758835918766189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888815/
https://www.ncbi.nlm.nih.gov/pubmed/29636827
http://dx.doi.org/10.1177/1758835918766189

Ejemplares similares